These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
92 related items for PubMed ID: 1803606
21. [Relationship between macrophage migration inhibitory factor and cardiac function in patients with congestive heart failure]. Liu Y, Yu XY, Lin QX, Yang M, Shan ZX, Zheng M. Di Yi Jun Yi Da Xue Xue Bao; 2003 Nov; 23(11):1169-70. PubMed ID: 14625178 [Abstract] [Full Text] [Related]
23. [The efficacy of treatment with the angiotensin-converting enzyme inhibitor ramipril in patients with congestive heart failure of rheumatic etiology]. Karakin AA, Khrustalev OA, Bol'shakova MA, Forsilov VE. Ter Arkh; 1996 Nov; 68(2):43-6. PubMed ID: 8771657 [No Abstract] [Full Text] [Related]
24. [Spontaneous and stimulus-induced arrhythmia behavior in dilated cardiomyopathy]. Gonska BD, Bethge KP, Kreuzer H. Z Kardiol; 1987 Sep; 76(9):546-53. PubMed ID: 2447707 [Abstract] [Full Text] [Related]
25. [Effects of digoxin on ventricular arrhythmia in patients with heart failure: relations with the state of the sympathetic-adrenal system]. Gabrusenko SA, Naumov VG, Khodzhakuliev BG, Masenko VP, Belenkov IuN. Kardiologiia; 1992 Apr; 32(4):20-4. PubMed ID: 1383593 [Abstract] [Full Text] [Related]
27. Comparison of levels of matrix metalloproteinase-2 and -3 in patients with ischemic cardiomyopathy versus nonischemic cardiomyopathy. Tziakas DN, Chalikias GK, Papaioakeim M, Hatzinikolaou EI, Stakos DA, Tentes IK, Papanas N, Kortsaris A, Maltezos E, Hatseras DI. Am J Cardiol; 2005 Nov 15; 96(10):1449-51. PubMed ID: 16275197 [Abstract] [Full Text] [Related]
28. Changes in natriuretic peptides following passive containment surgery in heart failure patients with dilated cardiomyopathy. Bredin F, Liska J, Franco-Cereceda A. Interact Cardiovasc Thorac Surg; 2009 Feb 15; 8(2):191-4. PubMed ID: 19008326 [Abstract] [Full Text] [Related]
37. [Effect of trekrezan on the lipid peroxidation in patients with chronic cardiac insufficiency]. Sabadyshin RO, Slipak OIa, Koval'chuk SF, D'iakov VM, Kazimirovskaia VB. Biull Eksp Biol Med; 1998 Aug 15; 126(8):186-8. PubMed ID: 9777233 [No Abstract] [Full Text] [Related]
38. Role of growth hormone in chronic heart failure: therapeutic implications. Volterrani M, Giustina A, Manelli F, Cicoira MA, Lorusso R, Giordano A. Ital Heart J; 2000 Nov 15; 1(11):732-8. PubMed ID: 11110515 [Abstract] [Full Text] [Related]
39. [The hemodynamic profile of amrinone and enoximone in patients with severe heart failure]. Saborowski F, Peters P, Schneider M. Z Kardiol; 1991 Nov 15; 80 Suppl 4():63-7. PubMed ID: 1833900 [Abstract] [Full Text] [Related]
40. [Hemodynamics with dobutamine and milrinone in patients with severe heart failure in an intra-individual comparison]. Mager G, Klocke RK, Volkmann A, Kux A, Höpp HW, Hilger HH. Z Kardiol; 1991 Feb 15; 80(2):149-57. PubMed ID: 2058247 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]